Paola Ghione

14PUBLICATIONS
136CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)BiomaterialsPredictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 10, 2026
Clinical outcomes, patterns of relapse and molecular landscape of advanced stage High Grade B-cell Lymphoma.

|Jun 30, 2026
Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKs.

|Jun 11, 2026
High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.

|Jun 13, 2025
BRCA1/2 impact on the development of implant-associated lymphoma in women with breast cancer and textured implants.

Paola Ghione, Diana Mandelker, Maria Arcila

|Feb 07, 2025
The prognostic value of POD24 in relapsed/refractory follicular lymphoma-A SCHOLAR-5 analysis.

Eve H Limbrick-Oldfield, Steve Kanters, Markqayne D Ray

|Dec 11, 2024
Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma.

Pallawi Torka, Tatyana Feldman, Kerry J Savage

Pageof 3

Frequent Collaborators

5 joint publications

Gilles Salles

4 joint publications

Pallawi Torka

4 joint publications

Ahmet Dogan

4 joint publications

Robert Stuver